Mineralocorticoid Receptors and Cardiovascular Damage
- 1 April 2006
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (4), 634-635
- https://doi.org/10.1161/01.HYP.0000203732.03784.3b
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive RatsHypertension, 2006
- Is aldosterone bad for the heart?Trends in Endocrinology & Metabolism, 2004
- Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular HypertrophyCirculation, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Selective Aldosterone Blockade Prevents Angiotensin II/Salt-Induced Vascular Inflammation in the Rat HeartEndocrinology, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies.Endocrinology, 1996
- Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid ReceptorScience, 1987